BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 2474624)

  • 1. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
    Molzer B; Kainz-Korschinsky M; Sundt-Heller R; Bernheimer H
    J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disorders related to the metabolism of phytanic acid.
    Stokke O; Skjeldal OH; Høie K
    Scand J Clin Lab Invest Suppl; 1986; 184():3-10. PubMed ID: 2438746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of peroxisomal disorders with neurological involvement.
    Molzer B
    Padiatr Padol; 1993; 28(1):43-8. PubMed ID: 8446428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.
    Poll-The BT; Skjeldal OH; Stokke O; Poulos A; Demaugre F; Saudubray JM
    Hum Genet; 1989 Jan; 81(2):175-81. PubMed ID: 2463966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
    Molzer B; Stöckler S; Bernheimer H
    Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very long-chain fatty acids in peroxisomal disease.
    Poulos A; Beckman K; Johnson DW; Paton BC; Robinson BS; Sharp P; Usher S; Singh H
    Adv Exp Med Biol; 1992; 318():331-40. PubMed ID: 1378993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.
    Poulos A; Singh H; Paton B; Sharp P; Derwas N
    Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders.
    Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; Heikoop J; van den Bosch H; Schram AW; Tager JM
    J Clin Invest; 1987 Dec; 80(6):1778-83. PubMed ID: 3680527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudo infantile Refsum's disease: catalase-deficient peroxisomal particles with partial deficiency of plasmalogen synthesis and oxidation of fatty acids.
    Aubourg P; Kremser K; Roland MO; Rocchiccioli F; Singh I
    Pediatr Res; 1993 Sep; 34(3):270-6. PubMed ID: 7510868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders.
    Van Veldhoven PP; Huang S; Eyssen HJ; Mannaerts GP
    J Inherit Metab Dis; 1993; 16(2):381-91. PubMed ID: 7692128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid composition of tissues in Refsum's disease (herodopathia atactica polyneuritiformis). Estimation of total phytanic acid accumulation.
    Malmendier CL; Jonniaux G; Voet W; Van Den Bergen CJ
    Biomedicine; 1974 Nov; 20(6):398-407. PubMed ID: 4141904
    [No Abstract]   [Full Text] [Related]  

  • 12. Complementation analysis of peroxisomal disorders and classical Refsum.
    Poll-The BT; Skjeldal OH; Stokke O; Demaugre F; Saudubray JM
    Prog Clin Biol Res; 1990; 321():537-43. PubMed ID: 1691507
    [No Abstract]   [Full Text] [Related]  

  • 13. Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders.
    Wanders RJ; van Roermund CW; van Wijland MJ; Heikoop J; Schutgens RB; Schram AW; Tager JM; van den Bosch H; Poll-Thé BT; Saudubray JM
    Clin Chim Acta; 1987 Jul; 166(2-3):255-63. PubMed ID: 2441904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders.
    Slawecki ML; Dodt G; Steinberg S; Moser AB; Moser HW; Gould SJ
    J Cell Sci; 1995 May; 108 ( Pt 5)():1817-29. PubMed ID: 7544797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy, and Refsum's disease: plasma changes and skin fibroblast phytanic acid oxidase.
    Poulos A; Sharp P; Fellenberg AJ; Danks DM
    Hum Genet; 1985; 70(2):172-7. PubMed ID: 2408988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisomal integral membrane proteins in livers of patients with Zellweger syndrome, infantile Refsum's disease and X-linked adrenoleukodystrophy.
    Small GM; Santos MJ; Imanaka T; Poulos A; Danks DM; Moser HW; Lazarow PB
    J Inherit Metab Dis; 1988; 11(4):358-71. PubMed ID: 2468817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peroxisomes and neurologic diseases].
    Sereni C; Paturneau-Jouas M
    Rev Neurol (Paris); 1989; 145(5):341-9. PubMed ID: 2472665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisomal functions in classical Refsum's disease: comparison with the infantile form of Refsum's disease.
    Wanders RJ; Heymans HS; Schutgens RB; Poll-Thé BT; Saudubray JM; Tager JM; Schrakamp G; van den Bosch H
    J Neurol Sci; 1988 Apr; 84(2-3):147-55. PubMed ID: 2454298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acids in peroxisomal disorders.
    Van Eldere JR; Parmentier GG; Eyssen HJ; Wanders RJ; Schutgens RB; Vamecq J; Van Hoof F; Poll-The BT; Saudubray JM
    Eur J Clin Invest; 1987 Oct; 17(5):386-90. PubMed ID: 2446876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Zellweger syndrome, neonatal adrenoleukodystrophy or infantile Refsum's disease in a case with generalized peroxisome defect?].
    Schmitt K; Molzer B; Stöckler S; Tulzer G; Tulzer W
    Wien Klin Wochenschr; 1993; 105(11):320-2. PubMed ID: 7687405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.